Stocks
ALX Oncology Holdings (ALXO) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -83.4 | -122.8 | -158.4 | -132.2 | -99.4 | -88.1 | ||
| Changes by years, y/y, % | +92% | +47% | +29% | -17% | -25% | +18.0% | |||
ALX Oncology Holdings. EBITDA US GAAP, bln rub
ALX Oncology Holdings. EBITDA US GAAP, changes, %
ALX Oncology Holdings. EBITDA US GAAP, sum by quarters, bln rub
ALX Oncology Holdings (ALXO) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -30.1 | -25.4 | -21.6 | -22.3 | -17.4 | -88.1 | |
| Changes by years, y/y, % | -14% | -35% | -28% | -22% | -42% | |||
| Changes by quarters, q/q, % | +6% | -16% | -15% | +3% | -22% | |||
